Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Market Analysis and Insights: Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
The global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Peripheral Parenteral Nutrition (PPN) accounting for % of the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market size is valued at US$ million in 2021, while the North America and Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market.
Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Scope and Market Size
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
By Region
By Company
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Peripheral Parenteral Nutrition (PPN)
1.2.3 Total Parenteral Nutrition (TPN)
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Home
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Perspective (2017-2028)
2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Growth Trends by Region
2.2.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Region (2017-2022)
2.2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2023-2028)
2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue (2017-2022)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Players (2017-2022)
3.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2021
3.5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Key Players Head office and Area Served
3.6 Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Type (2017-2022)
4.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2023-2028)
5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Application (2017-2022)
5.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
6.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
6.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
7.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
7.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
9.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Detail
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Detail
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Detail
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Detail
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Detail
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Detail
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Detail
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Detail
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Detail
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Detail
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Detail
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Peripheral Parenteral Nutrition (PPN)
Table 3. Key Players of Total Parenteral Nutrition (TPN)
Table 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2017-2022)
Table 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2023-2028)
Table 10. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Trends
Table 11. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
Table 12. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
Table 13. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
Table 14. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players (2017-2022)
Table 16. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2021)
Table 17. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
Table 21. Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2017-2022)
Table 25. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2023-2028)
Table 27. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2017-2022)
Table 29. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2023-2028)
Table 31. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028) & (US$ Million)
Table 41. Eurofarma Company Detail
Table 42. Eurofarma Business Overview
Table 43. Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 44. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 45. Eurofarma Recent Development
Table 46. Corporacion De Laboratorios Farmaceuticos Company Detail
Table 47. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 48. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 49. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 50. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 51. Baxter International Inc. Company Detail
Table 52. Baxter International Inc. Business Overview
Table 53. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 54. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 55. Baxter International Inc. Recent Development
Table 56. Kelun Pharma Company Detail
Table 57. Kelun Pharma Business Overview
Table 58. Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 59. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 60. Kelun Pharma Recent Development
Table 61. B. Braun Company Detail
Table 62. B. Braun Business Overview
Table 63. B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 64. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 65. B. Braun Recent Development
Table 66. Fresenius Company Detail
Table 67. Fresenius Business Overview
Table 68. Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 69. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 70. Fresenius Recent Development
Table 71. Teva Pharmaceutical Industries Company Detail
Table 72. Teva Pharmaceutical Industries Business Overview
Table 73. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 74. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 75. Teva Pharmaceutical Industries Recent Development
Table 76. Pfizer (Hospira) Company Detail
Table 77. Pfizer (Hospira) Business Overview
Table 78. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 79. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 80. Pfizer (Hospira) Recent Development
Table 81. Ostuka Pharmaceutical Company Detail
Table 82. Ostuka Pharmaceutical Business Overview
Table 83. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 84. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 85. Ostuka Pharmaceutical Recent Development
Table 86. Laboratorios Biogalenic Company Detail
Table 87. Laboratorios Biogalenic Business Overview
Table 88. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 89. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 90. Laboratorios Biogalenic Recent Development
Table 91. Laboratorios Finlay Company Detail
Table 92. Laboratorios Finlay Business Overview
Table 93. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
Table 94. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 95. Laboratorios Finlay Recent Development
Table 96. Grifols International Company Detail
Table 97. Grifols International Business Overview
Table 98. Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
Table 99. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 100. Grifols International Recent Development
Table 101. Fresenius Kabi Company Detail
Table 102. Fresenius Kabi Business Overview
Table 103. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
Table 104. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 105. Fresenius Kabi Recent Development
Table 106. Sichuan Kelun Pharmaceutical Company Detail
Table 107. Sichuan Kelun Pharmaceutical Business Overview
Table 108. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN)Product
Table 109. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022) & (US$ Million)
Table 110. Sichuan Kelun Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type: 2021 VS 2028
Figure 2. Peripheral Parenteral Nutrition (PPN) Features
Figure 3. Total Parenteral Nutrition (TPN) Features
Figure 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Home Case Studies
Figure 7. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Report Years Considered
Figure 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region: 2021 VS 2028
Figure 11. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players in 2021
Figure 12. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2021
Figure 14. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
Figure 16. United States Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
Figure 20. Germany Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2017-2028)
Figure 28. China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
Figure 36. Mexico Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2017-2028)
Figure 40. Turkey Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 43. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 44. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 45. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 46. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 47. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 48. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 49. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 50. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 51. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 52. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 53. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 54. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 55. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research